Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,891 | 7,905 | 5,950 | 3,929 | 1,944 |
| Depreciation Amortization | 147 | 597 | 443 | 301 | 151 |
| Income taxes - deferred | -77 | 93 | N/A | N/A | N/A |
| Accounts receivable | 97 | -117 | -341 | -442 | -385 |
| Accounts payable and accrued liabilities | 92 | -207 | -4 | -43 | 49 |
| Other Working Capital | -114 | -197 | -365 | -809 | 81 |
| Other Operating Activity | -296 | -600 | -367 | 19 | 108 |
| Operating Cash Flow | $1,740 | $7,474 | $5,316 | $2,955 | $1,948 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -85 | -307 | -214 | -152 | -85 |
| Purchase Of Investment | -1,000 | -2,000 | -1,500 | -800 | -900 |
| Sale Of Investment | 921 | 2,023 | 1,570 | 1,240 | 544 |
| Purchase Sale Intangibles | -4 | -53 | -30 | -10 | -8 |
| Other Investing Activity | -4 | -53 | -30 | -10 | -8 |
| Investing Cash Flow | $-168 | $-337 | $-174 | $278 | $-449 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -251 | -1,239 | -687 | -452 | -225 |
| Common Stock Issued | 133 | 180 | 151 | 125 | 102 |
| Common Stock Repurchased | -921 | -2,023 | -1,570 | -1,240 | -544 |
| Dividend Paid | -880 | -3,423 | -2,562 | -1,697 | -829 |
| Other Financing Activity | 36 | 60 | 46 | 34 | 30 |
| Financing Cash Flow | $-1,883 | $-6,445 | $-4,622 | $-3,230 | $-1,466 |
| Exchange Rate Effect | 44 | -52 | -28 | -4 | -10 |
| Beginning Cash Position | 1,251 | 610 | 610 | 610 | 610 |
| End Cash Position | 984 | 1,251 | 1,102 | 608 | 634 |
| Net Cash Flow | $-267 | $640 | $492 | $-2 | $23 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,740 | 7,474 | 5,316 | 2,955 | 1,948 |
| Capital Expenditure | -85 | -307 | -214 | -152 | -85 |
| Free Cash Flow | 1,655 | 7,167 | 5,102 | 2,803 | 1,863 |